QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序作者升序作者降序提交时间升序提交时间降序题名升序题名降序 Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study 期刊论文 ANTICANCER RESEARCH, 2019, 卷号: 39, 期号: 3 作者:  Cho, Byoung Chul;  De Pas, Tommaso;  Kalofonos, Haralabos;  Wang, Qun;  Ramlaus, Rodryg 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Non-small cell lung cancer  MAGE-A3 cancer immunotherapeutic  prognostic factors  placebo  overall survival   PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer 期刊论文 2016, 卷号: 34, 期号: 9, 页码: 953-+ 作者:  Senan, Suresh;  Brade, Anthony;  Wang, Lu-hua;  Vansteenkiste, Johan;  Dakhil, Shaker 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Final overall survival (OS) results of the phase III PROCLAIM trial: Pemetrexed (Pem), cisplatin (Cis) or etoposide (Eto), Cis plus thoracic radiation therapy (TRT) followed by consolidation cytotoxic chemotherapy (CTX) in locally advanced nonsqu 期刊论文 2015, 卷号: 33, 期号: 15 作者:  Senan, Suresh;  Brade, Anthony M.;  Wang, Luhua;  Vansteenkiste, Johan F.;  Dakhil, Shaker R. 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04 Final overall survival (OS) results of the phase III PROCLAIM trial: Pemetrexed (Pem), cisplatin (Cis) or etoposide (Eto), Cis plus thoracic radiation therapy (TRT) followed by consolidation cytotoxic chemotherapy (CTX) in locally advanced nonsqu 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2015-05-20 作者:  Senan, Suresh;  Brade, Anthony M.;  Wang, Luhua;  Vansteenkiste, Johan F.;  Dakhil, Shaker R. 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/13 PRELIMINARY SAFETY AND TREATMENT DELIVERY DATA DURING CONCURRENT PHASE OF CHEMORADIATION THERAPY OF THE PROCLAIM TRIAL: A PHASE 3 TRIAL OF PEMETREXED, CISPLATIN, AND RADIOTHERAPY FOLLOWED BY CONSOLIDATION PEMETREXED VERSUS ETOPOSIDE, CISPLATIN, A 期刊论文 2013, 卷号: 8, 页码: S551-S552 作者:  Vokes, Everett;  Wang, Luhua;  Vansteenkiste, Johan;  Dakhil, Shaker;  Biesma, Bonne 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13 pemetrexed  NSCLC  safety  PROCLAIM   Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non-Small-Cell Lung Cancer 期刊论文 2012, 卷号: 30, 期号: 25, 页码: 3084-3092 作者:  Paz-Ares, Luis G.;  Biesma, Bonne;  Heigener, David;  von Pawel, Joachim;  Eisen, Timothy 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/13